The Valley Desk

NCT07140900 · Interventional trial

Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer

Overall registry status Active not recruiting

Phase 1

Conditions Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov